TMCNet:  Research and Markets: Global Schizophrenia Report 2014 - Current and Future Players

[April 29, 2014]

Research and Markets: Global Schizophrenia Report 2014 - Current and Future Players

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/rp7fw4/pharmapoint) has announced the addition of the "PharmaPoint: Schizophrenia - Current and Future Players" report to their offering.

The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Schizophrenia Market. The report identifies and analyses the key companies shaping and driving the global Schizophrenia market. The report provides insight into the competitive Schizophrenia landscape, including new companies entering the market.


Scope

  • Investigation of current and future market competition for Schizophrenia
  • Competitor assessment
  • Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
  • Strategic assessment of the Schizophrenia sector through market impact analysis, future market scenario and company analysis

Key Topics Covered:

1 Tables & Figures

2 Introduction

3 Market Outlook

3.1 Global Markets

3.1.1 Forecast

3.1.2 Global Drivers and Barriers

4 Current and Future Players

4.1 Overview

4.2 Trends in Corporate Strategy

4.3 Company Profiles

4.3.1 Janssen Pharmaceuticals

4.3.2 Eli Lilly and Company

4.3.3 Roche

4.3.4 Alkermes

4.3.5 EnVivo Pharmaceuticals

5 Appendix

For more information visit http://www.researchandmarkets.com/research/rp7fw4/pharmapoint


[ Back To Cloud Computing 's Homepage ]